IMPACT Therapeutics
Signal active
Organization
Contact Information
Overview
IMPACT Therapeutics creates new treatments to treat cancer and other life-threatening disorders. The firm is committed to the discovery and development of targeted anti-cancer treatments based on synthetic lethality, hence offering patients novel targeted anti-cancer drugs.
About
Industries
Biotechnology, Pharmaceutical, Therapeutics
Founded
2009
Employees
51-100
Headquarters locations
Asia
Social
N/A
Profile Resume
IMPACT Therapeutics headquartered in Asia, operates in the Biotechnology, Pharmaceutical, Therapeutics sector. The company focuses on Biotechnology and has secured $10.5B in funding across 72 round(s). With a team of 51-100 employees, IMPACT Therapeutics is actively contributing to advancements in Biotechnology. Their latest funding round, Series B - IMPACT Therapeutics, raised $10.0M. Discover more about their projects, partnerships, and impact on our platform.
Funding Rounds
Funding rounds
6
Investors
6
Lead Investors
0
Total Funding Amount
$145.2M
Details
6
IMPACT Therapeutics has raised a total of $145.2M in funding over 6 rounds.
| Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
|---|---|---|---|---|
| 2022 | Late Stage Venture | |||
| 2024 | Late Stage Venture | 55.2M | ||
| 2014 | Early Stage Venture | |||
| 2016 | Early Stage Venture | 10.0M |
Investors
IMPACT Therapeutics is funded by 41 investors.
| Investor Name | Lead Investor | Funding Round | Partners |
|---|---|---|---|
| Lilly Asia Ventures | - | FUNDING ROUND - Lilly Asia Ventures | 10.0M |
| China Summit Capital | - | FUNDING ROUND - China Summit Capital | 10.0M |
| Guangzhou Yuexiu Industrial Investment Fund | - | FUNDING ROUND - Guangzhou Yuexiu Industrial Investment Fund | 10.0M |
| IMPACT Therapeutics | - | FUNDING ROUND - IMPACT Therapeutics | 10.0M |
Recent Activity
There is no recent news or activity for this profile.